MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Impact of Bilateral GPi Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease

J. Lee, S. Jo, M. Choi, SJ. Chung (Goyang-si, Republic of Korea)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS), Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Surgical Therapy

Objective: This study aimed to evaluate how bilateral Globus Pallidus internus (GPi) Deep Brain Stimulation (DBS) affects non-motor symptoms in individuals diagnosed with Parkinson’s disease (PD).

Background: Parkinson’s disease is a progressive neurodegenerative disorder that manifests with both motor impairments and a range of non-motor symptoms such as hyposmia, pain, neuropsychiatric issues, and autonomic dysfunction. While prior research has demonstrated that subthalamic nucleus DBS can enhance both motor and non-motor functions, the specific effects of GPi DBS on non-motor symptoms remain unclear.

Method: We conducted an analysis of Parkinson’s disease patients who underwent bilateral GPi DBS in 2022. To assess non-motor symptoms, we utilized the Non-Motor Symptoms Scale (NMSS), the Apathy Evaluation Scale (AES), the Hospital Anxiety and Depression Scale (HADS), and the Beck Depression Inventory (BDI). Evaluations were conducted before surgery and again one year post-DBS. Intra-group variations were examined using Wilcoxon signed-rank tests or paired T-tests when appropriate for parametric analysis.

Results: A total of eight patients were included in the study. The baseline Unified Parkinson’s Disease Rating Scale (UPDRS) score in the medication-off state was recorded at 89.1. Following GPi DBS, AES scores showed a reduction with borderline significance (46.8 vs. 40.4, p = 0.059). However, BDI scores did not exhibit a statistically significant difference between pre- and post-DBS evaluations (24.6 vs. 22.5, p = 0.660). Similarly, NMSS scores, its subcategories, and HADS scores showed no significant variations after the procedure.

Conclusion: Our findings suggest that apathy levels improved following GPi DBS in Parkinson’s disease patients. However, no statistically significant changes were observed in depression, anxiety, or NMSS scores. The absence of significant results may be due to the small sample size, highlighting the need for further studies with a larger cohort.

To cite this abstract in AMA style:

J. Lee, S. Jo, M. Choi, SJ. Chung. The Impact of Bilateral GPi Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/the-impact-of-bilateral-gpi-deep-brain-stimulation-on-non-motor-symptoms-in-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-impact-of-bilateral-gpi-deep-brain-stimulation-on-non-motor-symptoms-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley